2016 International Congress

Wednesday, June 22, 2016

12:00pm-1:30pm

Subthalamic neurons encode reward hypersensitivity and loss hyposensitivity in Parkinson’s patients with impulse control disorders

P.J. Rossi, A. Gunduz, M.S. Okun (Gainesville, FL, USA)

Parkinson's disease: Psychiatric manifestations  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Suicide attempts and Huntington’s disease: Perseveration, not just impulsivity

O.C. Roman, J.G. Stovall, D.O. Claassen (Nashville, TN, USA)

Huntington's disease  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Suppression of dyskinesia in Parkinson’s disease by electrical stimulation of dorsal subthalamic nucleus tissue

H.A.C. Wark, G.H. Duffley, C.R. Butson, L.E. Schrock (Salt Lake City, UT, USA)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Sustained effects of cerebellar transcranial direct current stimulation in patients with ataxia: A randomized, double blind, sham-controlled study

V. Dell'Era, A. Benussi, M. Cosseddu, A. Padovani, B. Borroni (Brescia, Italy)

Ataxiz, Choreas

12:00pm-1:30pm

Swallowing disorders characteristics and the relation to cognitive level, disease duration and disease severity in patients with Huntington’s disease

Y. Manor, D. Shpunt, N. Avniel, S. Assa, Y. Torner, A. Gad, A. Ezra, J. Knaani, A. Socher, Y. Oestriecher-Kedem, T. Gurevich (Tel Aviv, Israel)

Huntington's disease  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Symptom progression in a large cohort of Parkinson’s disease cases in a clinical practice setting

K. Markopoulou, A. Premkumar, B. Schoneburg, S. Walters, R. Frigerio, M. Szela, D.M. Maraganore (Glenview, IL, USA)

Phenomenology and clinical assessment of movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Synaptic biomarkers for cognitive decline in Lewy body dementias and Alzheimer’s disease. A mass spectrometry approach

E. Bereczki, R.M.M. Branca, P.T. Francis, J.H. Baek, J. Lehtio, D. Aarsland (Huddinge, Sweden)

Parkinson's disease: Cognition  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Targeted over-expression with AAV-mediated human α-synuclein in a rat model of Parkinson’s disease – Validation of novel fine motor functional effects

R. Pussinen, T. Ahtoniemi, T. Huhtala, O. Kontkanen, A. Nurmi (Kuopio, Finland)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Tau pathology in Huntington’s disease: A brief in vivo PET-imaging report

K. Giehl, K. Reetz, I. Dogan, C. Werner, J.B. Schulz, A. Drzezga, T. van Eimeren (Köln, Germany)

Huntington's disease  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Tau PET in Parkinson syndromes. A new diagnostic tool?

J. Hammes, G.N. Bischof, K. Giehl, Ö. Onur, A. Drzezga, T. Klockgether, T. van Eimeren (Cologne, Germany)

Neuroimaging (non-PD)  ·  Exhibit Hall located in Hall B, Level 2